Bioretec Oy (HEL:BRETEC)

Finland · Delayed Price · Currency is EUR

0.0132

-0.0048 (-26.67%)

At close: Apr 27, 2026

-99.37% (1Y)

Market Cap	406.40K
Revenue	n/a
Net Income	n/a
Shares Out	30.79M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,737,038
Average Volume	844,651
Open	0.0182
Previous Close	0.0180
Day's Range	0.0124 - 0.0220
52-Week Range	0.0118 - 2.3800
Beta	0.98
RSI	21.20
Earnings Date	May 15, 2026

About Bioretec Oy

Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatmen... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1998

Country Finland

Stock Exchange Nasdaq Helsinki

Ticker Symbol BRETEC

Full Company Profile

News

Bioretec Ltd (OHEL:BRETEC) Q4 2025 Earnings Report Preview: What To Expect

2 months ago - GuruFocus

Bioretec Board Approves Updated Strategy, Financial Targets For 2026-2028 Period

(RTTNews) - Bioretec (0TN.F, BRETEC.HE) said Board of Directors has approved the company's updated strategy for 2026-2028 and new financial targets for the strategy period. Bioretec's new financial ta...

4 months ago - Nasdaq

Bioretec Secures FDA Breakthrough Device Designation For RemeOs DrillPin

(RTTNews) - Bioretec Oy (0TN.F, BRETEC.HE) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its magnesium alloy technology-based, biodegradable RemeO...

4 months ago - Nasdaq

Bioretec Ltd's business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products

Bioretec Ltd Company announcement 15 May 2025 at 8:00 a.m. TAMPERE, Finland , May 15, 2025 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January- March 2025 . The com...

1 year ago - Benzinga